PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Acclaims Targos for Rapidly Establishing itself as a Leader in Customer-oriented Biomarker Services - Frost & Sullivan Acclaims Targos for Rapidly Establishing itself as a Leader in Customer-oriented Biomarker Services in the In Vitro Diagnostic Services Market - Frost.com
Frost & Sullivan Acclaims Targos for Rapidly Establishing itself as a Leader in Customer-oriented Biomarker Services

 

NewswireToday - /newswire/ - London, United Kingdom, 2012/03/28 - Frost & Sullivan Acclaims Targos for Rapidly Establishing itself as a Leader in Customer-oriented Biomarker Services in the In Vitro Diagnostic Services Market - Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Targos offers highly standardised clinical biomarker services for the development of the international pharmaceutical and diagnostic industry

Based on its recent analysis of the in vitro diagnostics services market, Frost & Sullivan recognizes Targos Molecular Pathology GmbH with the 2011 European Frost & Sullivan Award for Customer Service Leadership. Targos is uniquely positioned to combine expertise in clinical and molecular pathology and highly standardised biomarker analysis with strict quality assurance.

Targos has superior time lines of service compared to its competitors, which have a turn-around-time (TAT) for not less than four days. Targos, on the other hand, has optimized the TAT for clinical tissue biomarker analysis to as low as 24 hours, enabling faster diagnostic test results and timely delivery of diagnostic services.

"The Targos team has proven its meticulousness, reliability and flexibility in handling small and very large projects to customers' satisfaction," said Frost & Sullivan Research Analyst Srinivas Sashidhar. "It provides a wide range of biomarker and other diagnostic services for histopathology, tissue analysis, expression profiling, enzyme-linked immunosorbent assay (ELISA) testing and related services including project, data and logistic management of biomarker studies."

Its services and expertise have appealed to customers, evidenced by the extension of long-term projects from 5 to 20 years. Targos’ proficiency in in vitro diagnostics services has also allowed it to expand its customer base to more than 30 top pharmaceutical, biotech and diagnostic companies.

Targos has a well-organized cost structure, which can be tailored according to the project or service. The costs include project management, logistics management and data management fees. Its diagnostic service costs are lesser than its competitors’.

"The company has been inspected by the Food and Drug Administration (FDA) and participates in College of American Pathologists (CAP) proficiency testing and lab improvement programmes," notes Sashidhar. "Targos, in collaboration with its pathology partners, has acted as Good Clinical Practice-compliant patho-diagnostic reference centre for more than 75 pharmaco-diagnostic trials."

Each year, Frost & Sullivan presents this award to the company that demonstrates excellence in customer service leadership within its industry. The recipient company shows tremendous responsiveness to customer needs and continually focuses on long and short-term customer profitability goals. In addition, it demonstrates flexibility in tailoring its product offerings to suit customer businesses.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Targos Molecular Pathology GmbH
Targos Molecular Pathology GmbH since 2005 has established itself as a preferred service provider for standardized analytics of clinical biomarkers. Targos central lab services allow its customers to perform global diagnostic and pharmaceutical approval trials under strict quality standards and lowest possible turn-around times for molecular pathology analyses. Targos thrives for steady improvement of service quality and portfolio and has currently 70 employees in three German sites.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Acclaims Targos for Rapidly Establishing itself as a Leader in Customer-oriented Biomarker Services

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Emily Bailey - Frost.com 
+44(0)20 7915 7869 emily.bailey[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Rapid Recovery

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)